184 related articles for article (PubMed ID: 33923739)
1. Efficacy and Safety of Azelaic Acid Nanocrystal-Loaded In Situ Hydrogel in the Treatment of Acne Vulgaris.
Tomić I; Miočić S; Pepić I; Šimić D; Filipović-Grčić J
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33923739
[TBL] [Abstract][Full Text] [Related]
2. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
Schaller M; Sebastian M; Ress C; Seidel D; Hennig M
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):966-73. PubMed ID: 26915831
[TBL] [Abstract][Full Text] [Related]
3. Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris.
Shucheng H; Zhou X; Du D; Li J; Yu C; Jiang X
Dermatol Ther (Heidelb); 2024 May; 14(5):1293-1314. PubMed ID: 38734843
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.
Hebert A; Thiboutot D; Stein Gold L; Cartwright M; Gerloni M; Fragasso E; Mazzetti A
JAMA Dermatol; 2020 Jun; 156(6):621-630. PubMed ID: 32320027
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Facial Acne Vulgaris.
Hashim PW; Chen T; Harper JC; Kircik LH
J Drugs Dermatol; 2018 Jun; 17(6):641-645. PubMed ID: 29879251
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports.
Graupe K; Cunliffe WJ; Gollnick HP; Zaumseil RP
Cutis; 1996 Jan; 57(1 Suppl):20-35. PubMed ID: 8654128
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of 20% azelaic acid cream versus 5% tranexamic acid solution for the treatment of postinflammatory hyperpigmentation in patients with acne vulgaris: A single-blinded randomized clinical trial.
Sobhan M; Talebi-Ghane E; Poostiyan E
J Res Med Sci; 2023; 28():18. PubMed ID: 37213446
[TBL] [Abstract][Full Text] [Related]
8. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
Mazzetti A; Moro L; Gerloni M; Cartwright M
J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
[TBL] [Abstract][Full Text] [Related]
9. Hair Follicle-Targeted Delivery of Azelaic Acid Micro/Nanocrystals Promote the Treatment of Acne Vulgaris.
Ji Y; Li H; Li J; Yang G; Zhang W; Shen Y; Xu B; Liu J; Wen J; Song W
Int J Nanomedicine; 2024; 19():5173-5191. PubMed ID: 38855733
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris.
Iraji F; Sadeghinia A; Shahmoradi Z; Siadat AH; Jooya A
Indian J Dermatol Venereol Leprol; 2007; 73(2):94-6. PubMed ID: 17456913
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris.
Hoffman LK; Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2017 Jun; 16(6):534-538. PubMed ID: 28686770
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin.
Katsambas A; Graupe K; Stratigos J
Acta Derm Venereol Suppl (Stockh); 1989; 143():35-9. PubMed ID: 2528257
[TBL] [Abstract][Full Text] [Related]
13. Preparation of in situ hydrogels loaded with azelaic acid nanocrystals and their dermal application performance study.
Tomić I; Juretić M; Jug M; Pepić I; Cetina Čižmek B; Filipović-Grčić J
Int J Pharm; 2019 May; 563():249-258. PubMed ID: 30965120
[TBL] [Abstract][Full Text] [Related]
14. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris.
Thiboutot D
J Drugs Dermatol; 2008 Jan; 7(1):13-6. PubMed ID: 18246693
[TBL] [Abstract][Full Text] [Related]
15. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris.
Tanghetti EA; Kircik LH; Green LJ; Guenin E; Harris S; Martin G; Pillai R
J Drugs Dermatol; 2019 Jun; 18(6):542. PubMed ID: 31251546
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
Eichenfield LF; Lain T; Frankel EH; Jones TM; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
J Drugs Dermatol; 2016 Aug; 15(8):962-9. PubMed ID: 27537997
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
18. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne.
Thielitz A; Lux A; Wiede A; Kropf S; Papakonstantinou E; Gollnick H
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):789-96. PubMed ID: 25399481
[TBL] [Abstract][Full Text] [Related]
19. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
Stein Gold L; Pariser DM; Guenin E
J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
[TBL] [Abstract][Full Text] [Related]
20. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial.
Kim HK; Yeo IK; Li K; Kim BJ; Kim MN; Hong CK
Int J Dermatol; 2014 Aug; 53(8):1031-6. PubMed ID: 24962549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
